These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21964323)

  • 21. A c-Jun NH2-terminal kinase inhibitor SP600125 (anthra[1,9-cd]pyrazole-6 (2H)-one) blocks activation of pancreatic stellate cells.
    Masamune A; Kikuta K; Suzuki N; Satoh M; Satoh K; Shimosegawa T
    J Pharmacol Exp Ther; 2004 Aug; 310(2):520-7. PubMed ID: 15056726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SP600125 reduces lipopolysaccharide-induced apoptosis and restores the early-stage differentiation of osteoblasts inhibited by LPS through the MAPK pathway in MC3T3-E1 cells.
    Guo C; Wang SL; Xu ST; Wang JG; Song GH
    Int J Mol Med; 2015 May; 35(5):1427-34. PubMed ID: 25760015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.
    de la Croix Ndong J; Makowski AJ; Uppuganti S; Vignaux G; Ono K; Perrien DS; Joubert S; Baglio SR; Granchi D; Stevenson DA; Rios JJ; Nyman JS; Elefteriou F
    Nat Med; 2014 Aug; 20(8):904-10. PubMed ID: 24997609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteogenic responses to different concentrations/ratios of BMP-2 and bFGF in bone formation.
    Wang L; Huang Y; Pan K; Jiang X; Liu C
    Ann Biomed Eng; 2010 Jan; 38(1):77-87. PubMed ID: 19921434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study.
    Chen SH; Wang XL; Xie XH; Zheng LZ; Yao D; Wang DP; Leng Y; Zhang G; Qin L
    Acta Biomater; 2012 Aug; 8(8):3128-37. PubMed ID: 22543006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic enhancement of human bone marrow stromal cell proliferation and osteogenic differentiation on BMP-2-derived and RGD peptide concentration gradients.
    Moore NM; Lin NJ; Gallant ND; Becker ML
    Acta Biomater; 2011 May; 7(5):2091-100. PubMed ID: 21272672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.
    Rhodes SD; Wu X; He Y; Chen S; Yang H; Staser KW; Wang J; Zhang P; Jiang C; Yokota H; Dong R; Peng X; Yang X; Murthy S; Azhar M; Mohammad KS; Xu M; Guise TA; Yang FC
    J Bone Miner Res; 2013 Dec; 28(12):2476-89. PubMed ID: 23703870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JNK inactivation suppresses osteogenic differentiation, but robustly induces osteopontin expression in osteoblasts through the induction of inhibitor of DNA binding 4 (Id4).
    Kusuyama J; Amir MS; Albertson BG; Bandow K; Ohnishi T; Nakamura T; Noguchi K; Shima K; Semba I; Matsuguchi T
    FASEB J; 2019 Jun; 33(6):7331-7347. PubMed ID: 30884976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.
    Guang LG; Boskey AL; Zhu W
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1813-20. PubMed ID: 23742988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quinoline compound KM11073 enhances BMP-2-dependent osteogenic differentiation of C2C12 cells via activation of p38 signaling and exhibits in vivo bone forming activity.
    Baek SH; Choi SW; Park SJ; Lee SH; Chun HS; Kim SH
    PLoS One; 2015; 10(3):e0120150. PubMed ID: 25789987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphatidylserine enhances osteogenic differentiation in human mesenchymal stem cells via ERK signal pathways.
    Xu C; Zheng Z; Fang L; Zhao N; Lin Z; Liang T; Zhai Z; Zhou J
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1783-8. PubMed ID: 23827636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-Jun NH2 terminal kinase inhibitor SP600125.
    Williams AS; Issa R; Leung SY; Nath P; Ferguson GD; Bennett BL; Adcock IM; Chung KF
    J Pharmacol Exp Ther; 2007 Jul; 322(1):351-9. PubMed ID: 17460151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
    Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
    Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a.
    Liu R; Ginn SL; Lek M; North KN; Alexander IE; Little DG; Schindeler A
    BMC Musculoskelet Disord; 2009 May; 10():51. PubMed ID: 19442313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release characteristics and osteogenic activity of recombinant human bone morphogenetic protein-2 grafted to novel self-assembled poly(lactide-co-glycolide fumarate) nanoparticles.
    Mercado AE; Ma J; He X; Jabbari E
    J Control Release; 2009 Dec; 140(2):148-56. PubMed ID: 19699244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation.
    Matsuguchi T; Chiba N; Bandow K; Kakimoto K; Masuda A; Ohnishi T
    J Bone Miner Res; 2009 Mar; 24(3):398-410. PubMed ID: 19016586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
    Xu J; Ismat FA; Wang T; Yang J; Epstein JA
    Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative regulation of adipogenesis from human mesenchymal stem cells by Jun N-terminal kinase.
    Tominaga S; Yamaguchi T; Takahashi S; Hirose F; Osumi T
    Biochem Biophys Res Commun; 2005 Jan; 326(2):499-504. PubMed ID: 15582605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effect of BMP9 and TGF-β in the proliferation and differentiation of osteoblasts.
    Li XL; Liu YB; Ma EG; Shen WX; Li H; Zhang YN
    Genet Mol Res; 2015 Jul; 14(3):7605-15. PubMed ID: 26214439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Takai S; Tokuda H; Hanai Y; Harada A; Yasuda E; Matsushima-Nishiwaki R; Kato H; Ogura S; Ohta T; Kozawa O
    J Bone Miner Res; 2007 Mar; 22(3):337-46. PubMed ID: 17181399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.